Brewin Dolphin LTD Brainstorm Cell Therapeutics Inc. Transaction History

Brewin Dolphin LTD

  • $2.08 Billion
  • Q2 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Nov 09, 2023
BUY
$3.99 - $17.73 $1,197 - $5,319
300 Added 75.0%
700 $3.17 Million
Q3 2020

Nov 09, 2023
BUY
$11.19 - $16.92 $4,476 - $6,768
400 New
400 $6.77 Million
Q1 2018

Nov 09, 2023
SELL
$3.01 - $3.77 $1,408 - $1,764
-468 Closed
0 $0
Q3 2017

Nov 09, 2023
BUY
$3.98 - $4.36 $1,862 - $2,040
468
468 $1.93 Million

Others Institutions Holding BCLI

# of Institutions
41
Shares Held
10.8M
Call Options Held
160K
Put Options Held
30.5K
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $82.8M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email